Vaccine News and Research

RSS

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

New Proof-of-Concept Model for Delivering Gene Editing Tools to Treat Blood Disorders

In a step forward in the development of genetic medicines, researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have developed a proof-of-concept model for delivering gene editing tools to treat blood disorders, allowing for the modification of diseased blood cells directly within the body.

28 Jul 2023

Analyzing the Possibility to Design Improved Vaccines

A new paper in Biology Methods & Protocols, published by Oxford University Press, shows it may be possible to design vaccines that will induce a stronger immune response to infecting pathogens, such as the virus causing COVID-19.

26 Jul 2023

LION™-Formulated repRNA in Next-Gen repRNA Vaccine Platform Appears Promising

The creation of new vaccination technologies continues to be at the forefront of scientific inquiry as the globe fights numerous infectious illnesses. Recent research on illnesses like COVID-19 has shown promise for mRNA-based vaccines and their use of lipid nanoparticles (LNPs) for delivery.

25 Jul 2023

New Vaccine Shows Promise in Combating MenB

Investigators from the Universities of Surrey and Oxford have declared that a vaccine candidate that can shield children from Meningococcal group B (MenB), which can cause meningitis, has advanced to clinical development.

19 Jul 2023

'Purecap' Technique Produces Highly Active mRNA Vaccines with Lower Immunostimulatory Activity

A research group from Japan has developed a method to produce highly active mRNA vaccines at high purity using a unique cap to easily separate the desired capped mRNA.

6 Jul 2023

New Nanoparticle Developed Helps Improve the Delivery of mRNA-Based Vaccines

Johns Hopkins Medicine scientists say they have developed a nanoparticle -; an extremely tiny biodegradable container -; that has the potential to improve the delivery of messenger ribonucleic acid (mRNA)-based vaccines for infectious diseases such as COVID-19, and vaccines for treating non-infectious diseases including cancer.

29 Jun 2023

Breakthrough: Sequencing Functional Antibody Proteins Directly from Human Blood

Rapid Novor Inc., the world’s leader in mass spectrometry (MS)-based antibody protein sequencing, announced today that its REpAb® antibody discovery platform was used to successfully sequence a complex mixture of functional antibodies directly from the serum of a human patient after receiving a COVID-19 vaccine.

6 Jun 2023

Study Characterizes the Properties of MAIT Cells in Mouse Lung

A population of unconventional white blood cells has recently captured the attention of immunologists and clinicians alike.

26 May 2023

New Platform for Production of Synthetic Nitrated Proteins in Bacteria

In this study, the researchers focused on para-nitro-L-phenylalanine (pN-Phe), a non-standard amino acid that is neither one of the twenty standard amino acids nor been observed in nature.

24 May 2023

'Lost' Immune Cells Could be Partly Blamed for Impaired Vaccine Responses During Aging

Understanding the ways our immune response changes as we age holds the key to designing better vaccines and boosting protection for people most at risk.

23 May 2023

Seasonal Behavior of SARS-CoV-2 is Genetically Encoded, Study Suggests

As the northern hemisphere heads into summer, we may be in for a COVID-19 reprieve. Not because the pandemic is over; the Omicron subvariant 'Arcturus' is still creeping upward and causing new symptoms.

15 May 2023

First Gene-Edited Calf Produced With Resistance to Bovine Viral Diarrhea Virus

Scientists have collaborated to produce the first gene-edited calf with resistance to bovine viral diarrhea virus (BVDV), a virus that costs the U.S. cattle sector billions of dollars annually.

10 May 2023

New Insights on Cases of Post-Vaccine Heart Inflammation

Public health experts discovered an increase in cases of myocarditis, an inflammation of heart muscle, after the introduction of the new COVID-19 vaccinations two years ago, particularly in young males who had received mRNA vaccines.

8 May 2023

Researchers Publish a Comprehensive Study of Global COVID-19 Variant Transitions

A team of researchers at Los Alamos National Laboratory recently published the most comprehensive study of global COVID-19 variant transitions, which showed significant diversity in variant spread around the globe related to vaccination rates, number of co-circulating variants and immunity from previous infection.

4 May 2023

Vaccine News and Research

New Proof-of-Concept Model for Delivering Gene Editing Tools to Treat Blood Disorders

Analyzing the Possibility to Design Improved Vaccines

LION™-Formulated repRNA in Next-Gen repRNA Vaccine Platform Appears Promising

New Vaccine Shows Promise in Combating MenB

'Purecap' Technique Produces Highly Active mRNA Vaccines with Lower Immunostimulatory Activity

New Nanoparticle Developed Helps Improve the Delivery of mRNA-Based Vaccines

Breakthrough: Sequencing Functional Antibody Proteins Directly from Human Blood

Study Characterizes the Properties of MAIT Cells in Mouse Lung

New Platform for Production of Synthetic Nitrated Proteins in Bacteria

'Lost' Immune Cells Could be Partly Blamed for Impaired Vaccine Responses During Aging

Seasonal Behavior of SARS-CoV-2 is Genetically Encoded, Study Suggests

First Gene-Edited Calf Produced With Resistance to Bovine Viral Diarrhea Virus

New Insights on Cases of Post-Vaccine Heart Inflammation

Researchers Publish a Comprehensive Study of Global COVID-19 Variant Transitions

Argonne's Advanced Photon Source Helps Identify New Antibodies Against Coronaviruses

Some Promising Human Antibodies can Fight New Variants of SARS-CoV-2

Increased Fucose Digestion by Gut Bacteria Linked to Lower Immune Responses to COVID-19 Vaccine

Study Provides Insight into the Formation of Protective Memory T Cells Against Salmonella

A Nanoplasmonics Approach to Observe Real-Time Production of Cell Secretions

Organoid Platform Could Help Reduce the Time for Developing New Conjugate Vaccines

Quorum Bio: Where Synthetic Biology Meets Sustainable Farming

Diagnostic Biochips: Pioneering Brain Research Tools for the Future

Commercializing Innovation in a Life Sciences Ecosystem

Latest in Genomics